Cullen/Frost Bankers’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18M Buy
81,382
+4,135
+5% +$1.14M 0.18% 115
2026
Q1
$22.8M Buy
77,247
+2,202
+3% +$654K 0.26% 84
2025
Q4
$20.5M Sell
75,045
-320
-0.4% -$87K 0.23% 98
2025
Q3
$20.4M Sell
75,365
-1,252
-2% -$341K 0.24% 94
2025
Q2
$21.1M Buy
76,617
+1,617
+2% +$440K 0.26% 89
2025
Q1
$19.9M Buy
75,000
+1,088
+1% +$268K 0.28% 89
2024
Q4
$17.2M Buy
73,912
+1,157
+2% +$266K 0.23% 101
2024
Q3
$16.1M Buy
72,755
+1,505
+2% +$311K 0.22% 114
2024
Q2
$14M Buy
71,250
+2,386
+3% +$493K 0.2% 116
2024
Q1
$14.8M Buy
68,864
+1,299
+2% +$273K 0.22% 115
2023
Q4
$14.2M Buy
67,565
+4,874
+8% +$1.04M 0.22% 112
2023
Q3
$12.6M Buy
62,691
+5,480
+10% +$1.09M 0.22% 114
2023
Q2
$10.6M Buy
57,211
+7,619
+15% +$1.41M 0.18% 130
2023
Q1
$9.5M Buy
49,592
+21,385
+76% +$3.87M 0.17% 144
2022
Q4
$4.74M Buy
28,207
+6,397
+29% +$1.11M 0.09% 192
2022
Q3
$3.86M Buy
21,810
+6,889
+46% +$1.36M 0.09% 182
2022
Q2
$3.05M Buy
14,921
+13,199
+766% +$2.8M 0.07% 202
2022
Q1
$410K Buy
1,722
+59
+4% +$13.9K 0.01% 429
2021
Q4
$381K Buy
1,663
+1
+0.1% +$220 0.01% 447
2021
Q3
$321K Sell
1,662
-131
-7% -$26.5K 0.01% 458
2021
Q2
$381K Sell
1,793
-407
-19% -$85.9K 0.01% 442
2021
Q1
$449K Sell
2,200
-7
-0.3% -$1.38K 0.01% 397
2020
Q4
$404K Sell
2,207
-141
-6% -$24K 0.01% 384
2020
Q3
$393K Buy
2,348
+473
+25% +$79.7K 0.01% 369
2020
Q2
$305K Sell
1,875
-28
-1% -$5.02K 0.01% 387
2020
Q1
$329K Sell
1,903
-69
-3% -$13.7K 0.01% 319
2019
Q4
$397K Sell
1,972
-207
-9% -$42.5K 0.01% 332
2019
Q3
$460K Sell
2,179
-224
-9% -$46.8K 0.01% 321
2019
Q2
$467K Buy
2,403
+23
+1% +$4.24K 0.01% 312
2019
Q1
$391K Buy
2,380
+464
+24% +$82K 0.01% 316
2018
Q4
$360K Sell
1,916
-224
-10% -$41.4K 0.01% 309
2018
Q3
$365K Buy
2,140
+91
+4% +$15.3K 0.01% 322
2018
Q2
$335K Sell
2,049
-984
-32% -$161K 0.01% 334
2018
Q1
$490K Sell
3,033
-8
-0.3% -$1.27K 0.01% 305
2017
Q4
$444K Sell
3,041
-205
-6% -$29.2K 0.01% 301
2017
Q3
$440K Sell
3,246
-1,036
-24% -$131K 0.01% 296
2017
Q2
$536K Sell
4,282
-419
-9% -$50.1K 0.02% 274
2017
Q1
$559K Sell
4,701
-149
-3% -$17.9K 0.02% 267
2016
Q4
$560K Sell
4,850
-391
-7% -$43.5K 0.02% 267
2016
Q3
$548K Sell
5,241
-286
-5% -$29.9K 0.02% 266
2016
Q2
$538K Sell
5,527
-159
-3% -$15K 0.02% 270
2016
Q1
$546K Sell
5,686
-100
-2% -$9.1K 0.02% 268
2015
Q4
$525K Sell
5,786
-310
-5% -$29.2K 0.02% 270
2015
Q3
$566K Sell
6,096
-305
-5% -$29K 0.02% 267
2015
Q2
$596K Sell
6,401
-100
-2% -$9.33K 0.02% 281
2015
Q1
$616K Sell
6,501
-88
-1% -$8.15K 0.02% 279
2014
Q4
$584K Sell
6,589
-290
-4% -$24.6K 0.02% 286
2014
Q3
$550K Sell
6,879
-50
-0.7% -$3.77K 0.02% 291
2014
Q2
$492K Sell
6,929
-25,311
-79% -$1.78M 0.02% 298
2014
Q1
$2.39M Sell
32,240
-140
-0.4% -$10.6K 0.1% 178
2013
Q4
$2.54M Sell
32,380
-272
-0.8% -$21.3K 0.11% 171
2013
Q3
$2.41M Sell
32,652
-5,762
-15% -$425K 0.12% 170
2013
Q2
$2.92M Buy
+38,414
New +$2.52M 0.15% 162

Other funds holding CME

Cullen/Frost Bankers's CME Position: Q2 2026 in Review

Cullen/Frost Bankers increased its CME Group (CME) stake by 5.4% in Q2 2026, buying an estimated $1.14M and bringing the position to 81,382 shares worth $18M. The position accounts for 0.18% of the portfolio, ranked #115.

Cullen/Frost Bankers first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $22.8M in Q1 2026. 956 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Cullen/Frost Bankers held 81,382 shares of CME Group worth $18M as of Q2 2026.
  • Cullen/Frost Bankers bought 4,135 CME Group shares in Q2 2026, an estimated $1.14M.
  • CME Group made up 0.18% of Cullen/Frost Bankers's portfolio in Q2 2026, its #115 holding.
  • Cullen/Frost Bankers first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Cullen/Frost Bankers's CME Group position peaked at $22.8M in Q1 2026.
  • 956 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.